phase 1 adaptive dose-escalation study of mycophenolate mofetil (MMF) in combination with temozolomide (TMZ) for patients with newly diagnosed glioblastoma
霉酚酸酯(MMF)联合替莫唑胺(TMZ)治疗新诊断胶质母细胞瘤患者的 1 期适应性剂量递增研究
基本信息
- 批准号:10468354
- 负责人:
- 金额:$ 43.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-17 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Atique U. Ahmed其他文献
Glioblastoma recurrence and the role of MGMT promoter methylation
胶质母细胞瘤复发和 MGMT 启动子甲基化的作用
- DOI:
10.1101/317636 - 发表时间:
2018 - 期刊:
- 影响因子:0
- 作者:
K. Storey;K. Leder;A. Hawkins;K. Swanson;Atique U. Ahmed;R. Rockne;J. Foo - 通讯作者:
J. Foo
Beyond the brain: exploring the impact of animal models of leptomeningeal disease from solid tumors
- DOI:
10.1186/s40478-025-01959-4 - 发表时间:
2025-05-19 - 期刊:
- 影响因子:5.700
- 作者:
Jillyn R. Turunen;Priya Kumthekar;Atique U. Ahmed - 通讯作者:
Atique U. Ahmed
EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY
实验治疗学和药理学
- DOI:
- 发表时间:
2013 - 期刊:
- 影响因子:0
- 作者:
C. Aaberg;Louise Fogh;Bo Halle;V. Jensen;N. Brünner;B. Kristensen;T. Abe;Y. Momii;J. Watanabe;I. Morisaki;A. Natsume;T. Wakabayashi;M. Fujiki;Beatriz Aldaz;A. Fabius;J. Silber;Girish Harinath;T. Chan;J. Huse;S. Anai;T. Hide;Hideo Nakamura;K. Makino;S. Yano;J. Kuratsu;I. Balyasnikova;M. Prasol;Deepak K. Kanoija;K. Aboody;M. Lesniak;T. Barone;C. Burkhart;A. Purmal;A. Gudkov;K. Gurova;R. Plunkett;K. Barton;Katherine L. Misuraca;Francisco J. Cordero;E. Dobrikova;H. Min;M. Gromeier;D. Kirsch;O. Becher;L. B. Pont;J. Kloezeman;M. Bent;R. Kanaar;A. Kremer;S. Swagemakers;P. French;C. Dirven;M. Lamfers;S. Leenstra;R. Balvers;A. Kleijn;S. Lawler;X. Gong;A. Andres;Joseph A. Hanson;J. Delashaw;D. Bota;Chiao;N. Yao;W. Chuang;Chen Chang;Pin;Chiung;Kuo;Yuhu Cheng;Qing;R. Morshed;Yu Han;B. Auffinger;D. Wainwright;Lingjiao Zhang;Alex L. Tobias;E. Rincon;B. Thaci;Atique U. Ahmed;Chuang He;Young A. Choi;Hetal Pandya;D. Gibo;Isabela Fokt;W. Priebe;W. Debinski;Yevgen Chornenkyy;S. Agnihotri;P. Buczkowicz;P. Rakopoulos;A. Morrison;M. Barszczyk;C. Hawkins;Sylvia A. Chung;S. Decollogne;Peter P. Luk;Han Shen;Wendy Ha;B. Day;B. Stringer;P. Hogg;P. Dilda;K. McDonald;S. Moore;M. Hayden;J. Bergen;YouRong S. Su;H. Rayburn;M. Edwards;M. Scott;J. Cochran;Arabinda Das;A. Varma;G. Wallace;Yaenette N. Dixon;W. A. Vandergrift;P. Giglio;S. Ray;Sunil J. Patel;N. Banik;T. Dasgupta;A. Olow;Xiaodong Yang;S. Mueller;M. Prados;C. James;D. Haas;Nimita Dave;P. Desai;G. Gudelsky;L. Chow;K. LaSance;X. Qi;J. Driscoll;K. Ebsworth;M. Walters;L. Ertl;Yu Wang;Robert D. Berahovic;J. McMahon;J. Powers;J. Jaén;T. Schall;Z. Eroglu;J. Portnow;Arianne D. Sacramento;Elizabeth Garcia;A. Raubitschek;T. Synold;S. Esaki;S. Rabkin;R. Martuza;H. Wakimoto;S. Ferluga;C. M. L. Tomé;H. Førde;I. A. Netland;L. Sleire;B. Skeie;P. Enger;D. Goplen;M. Giladi;A. Tichon;R. Schneiderman;Y. Porat;M. Munster;Matan Dishon;U. Weinberg;E. Kirson;Yoram Wasserman;Y. Palti;D. Gramatzki;M. Staudinger;K. Frei;M. Peipp;M. Weller;C. Grasso;Lining Liu;Noah E. Berlow;L. Davis;M. Fouladi;A. Gajjar;Elaine C. Huang;E. Hulleman;M. Hutt;C. Keller;Xiao;P. Meltzer;Martha Quezado;M. Quist;Eric H. Raabe;P. Spellman;Nathalène Truffaux;Dannis van Vurden;Nicholas J. Wang;K. Warren;R. Pal;J. Grill;Michelle Monje;A. Green;S. Ramkissoon;D. McCauley;K. Jones;J. Perry;L. Ramkissoon;C. Maire;S. Shacham;K. Ligon;A. Kung;Katarzyna Zielinska;V. Grozman;J. Tu;K. Viktorsson;R. Lewensohn;Shiv K. Gupta;Ann C Mladek;K. Bakken;B. Carlson;F. Boakye;S. Kizilbash;M. Schroeder;J. Reid;J. Sarkaria;P. Hadaczek;T. Ozawa;L. Soroceanu;Y. Yoshida;Lisa Matlaf;Eric Singer;Estefania Fiallos;C. Cobbs;R. Hashizume;M. Tom;Yuichiro Ihara;R. Santos;J. D. L. Torre;Edgar L. Lepe;T. Waldman;D. James;Xi Huang;Lu Yu;N. Gupta;D. Solomon;Zhiguo Zhang;Takuro Hayashi;K. Adachi;S. Nagahisa;M. Hasegawa;Y. Hirose;M. Gephart;YouRong S. Su;Shawn D. Hingtgen;Randa Kasmieh;Irina Nesterenko;Jose;R. Dash;D. Sarkar;P. Fisher;K. Shah;Eric A. Horne;P. Diaz;N. Stella;Hongwei Yang;Tiffany T. Huang;J. Hlavaty;Derek Ostertag;Fernando Lopez Espinoza;B. Martin;H. Petznek;Maria E. Rodriguez;C. Ibañez;N. Kasahara;W. Günzburg;H. Gruber;D. Pertschuk;D. Jolly;J. Robbins;B. Hurwitz;J. Yoo;Chelsea M Bolyard;Jun‐ge Yu;Jeffery Wojton;Jianying Zhang;Zachary Bailey;D. Eaves;T. Cripe;M. Old;B. Kaur;L. Serwer;N. L. Moan;Sarah W S Ng;N. Butowski;A. Krtolica;S. Cary;T. Johns;S. Greenall;J. Donoghue;T. Adams;G. Karpel;M. Westhoff;R. Kast;A. Dwucet;C. Wirtz;K. Debatin;M. Halatsch;N. Merkur;Forrest M. Kievit;Zachary Stephen;Kui Wang;D. Kolstoe;J. Silber;R. Ellenbogen;Miqin Zhang;G. Kitange;Erik S. Haefner;Kristina H. Knubel;Ben M. Pernu;A. Sufit;Angela M Pierce;Sarah Nelson;A. Keating;S. S. Jensen;B. Kristensen;J. Lachowicz;M. Demeule;A. Régina;S. Tripathy;J. Curry;T. Nguyen;J. Castaigne;Tina N. Davis;A. Davis;Kevin Tanaka;T. Keating;Jennifer A. Getz;G. Kapp;J. M. Romero;Sang Y Lee;Srinivasa R. Ramisetti;Becky Slagle;Arun Sharma;J. Connor;Wen‐Shin Lee;M. Kluk;J. Aster;K. Ligon;Stella Sun;Derek Lee;A. Ho;J. Pu;Ziao Zhang;N. Lee;P. Day;G. Leung;Zhiguo Liu;Xiaoli Liu;A. Madhankumar;P. Miller;B. Webb;J. Connor;Qing X. Yang;Merryl R. Lobo;Sarah Green;M. Schabel;Y. Gillespie;R. Woltjer;M. Pike;Yu;J. D. L. Torre;H. A. Luchman;O. Stechishin;Stephanie A Nguyen;J. Cairncross;S. Weiss;X. Lun;J. Wells;X. Hao;Jun Zhang;Natalie Grinshtein;David L. Kaplan;Artee Luchman;D. Senger;S. Robbins;A. Madhankumar;Elias B Rizk;Russell Payne;Annie Park;Min Pang;K. Harbaugh;Anette Wilisch;D. Pachow;E. Kirches;C. Mawrin;S. Mcdonell;Ji Liang;Y. Piao;N. Nguyen;A. Yung;R. Verhaak;E. Sulman;C. Stephan;F. Lang;J. Groot;Yoshihumi Mizobuchi;Toshiyuki Okazaki;T. Kageji;Kazuyuki Kuwayama;K. Kitazato;H. Mure;Keijiro Hara;R. Morigaki;K. Matsuzaki;Kohei Nakajima;S. Nagahiro;S. Kumala;M. Heravi;S. Dević;T. Muanza;Kristina H. Knubel;A. Neuwelt;Tam Nguyen;Y. J. Wu;A. Donson;Rajeev Vibhakar;Sujatha Venkatamaran;V. Amani;E. Neuwelt;L. Rapkin;N. Foreman;Fady Ibrahim;P. New;K. Cui;Hong Zhao;D. Chow;W. Stephen;Kyoko Nozue;M. Nagane;K. McDonald;D. Ogawa;E. Chiocca;J. Godlewski;Akshal S. Patel;Nagarekha Pasupuleti;F. Gorin;Anthony Valenzuela;Leonardo J. Leon;K. Carraway;Chepapil Ramachandran;S. Nair;Karl;Z. Khatib;E. Escalon;S. Melnick;Andrew Phillips;E. Boghaert;Kedar S Vaidya;P. Ansell;D. Shalinsky;Yumin Zhang;Martin J. Voorbach;Sarah R. Mudd;K. Holen;R. Humerickhouse;E. Reilly;S. Parab;Oscar R. Diago;D. Jolly;T. Ryken;Supreet Agarwal;M. Al;M. Alqudah;Zita A. Sibenaller;Mahfoud Assemolt;K. Sai;Wen;Weiping Li;Zhongwu Chen;R. Saito;Y. Sonoda;Masayuki Kanamori;Y. Yamashita;T. Kumabe;T. Tominaga;G. Sarkar;G. Curran;R. Jenkins;R. Scharnweber;Yuki Kato;Jeff Lin;R. Everson;H. Soto;C. Kruse;L. Liau;R. Prins;Samantha L Semenkow;Q. Chu;C. Eberhart;Rajarshi Sengupta;J. Marassa;D. Piwnica;J. Rubin;R. Shai;Tatyana Pismenyuk;Itai Moshe;Tamar Fisher;Shani Freedman;A. Simon;N. Amariglio;G. Rechavi;A. Toren;M. Yalon;Y. Shimazu;K. Kurozumi;T. Ichikawa;K. Fujii;Manabu Onishi;Joji Ishida;T. Oka;Masami Watanabe;Y. Nasu;H. Kumon;I. Date;R. Sirianni;Rebecca L. McCall;J. Spoor;M. V. D. Kaaij;Mieke Geurtjens;Omid Veiseh;Chen Fang;M. Leung;G. Strohbehn;K. Atsina;T.R. Patel;J. Piepmeier;Jiangbing Zhou;W. Saltzman;Masamichi Takahashi;G. Valdes;Akihito Inagaki;Shuichi Kamijima;K. Hiraoka;E. Micewicz;W. McBride;K. Iwamoto;C. McCully;J. Bacher;T. Thomas;R. Murphy;E. Steffen;R. Mcallister;Devang Pastakia;B. Widemann;H. Yang;M. Hua;Hao;Eric C. Woolf;M. Abdelwahab;Kathryn E. Fenton;Qingwei Liu;G. Turner;M. Preul;A. Scheck;W. Shen;Dennis Brown;H. Pedersen;Jie Zhang;S. Hariono;Tsun‐Wen Yao;Angadpreet Sidhu;W. Weiss;T. Nicolaides;Temidayo O B Olusanya - 通讯作者:
Temidayo O B Olusanya
Interaction between DNA damage response, translation and apoptosome determines cancer susceptibility to TOP2 poisons
DNA 损伤反应、翻译和凋亡体之间的相互作用决定了癌症对 TOP2 毒物的易感性
- DOI:
10.1101/614024 - 发表时间:
2019 - 期刊:
- 影响因子:0
- 作者:
Chidiebere U. Awah;Li Chen;M. Bansal;A. Mahajan;Jan Winter;Meeki K. Lad;L. Warnke;E. González;Cheol Park;Zhang Daniel;Eric Feldstein;Dou Yu;Markella Zannikou;I. Balyasnikova;Regina T. Martuscello;Silvana Konerman;Balázs Győrffy;K. Burdett;D. Scholtens;R. Stupp;Atique U. Ahmed;P. Hsu;A. Sonabend - 通讯作者:
A. Sonabend
Activation of dopamine receptor 2 (DRD2) prompts transcriptomic and metabolic plasticity in glioblastoma
多巴胺受体 2 (DRD2) 的激活促进胶质母细胞瘤的转录组和代谢可塑性
- DOI:
10.1101/454389 - 发表时间:
2018 - 期刊:
- 影响因子:0
- 作者:
Seamus Caragher;Jack M. Shireman;Mei Huang;J. Miska;Cheol Shivani Baisiwala;Hong Park;Miranda R Saathoff;L. Warnke;Ting Xiao;M. Lesniak;David James;H. Meltzer;A. Tryba;Atique U. Ahmed - 通讯作者:
Atique U. Ahmed
Atique U. Ahmed的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Atique U. Ahmed', 18)}}的其他基金
phase 1 adaptive dose-escalation study of mycophenolate mofetil (MMF) in combination with temozolomide (TMZ) for patients with newly diagnosed glioblastoma
霉酚酸酯(MMF)联合替莫唑胺(TMZ)治疗新诊断胶质母细胞瘤患者的 1 期适应性剂量递增研究
- 批准号:
10478885 - 财政年份:2018
- 资助金额:
$ 43.94万 - 项目类别:
A Phase 1 Adaptive Dose Escalation Study of Mycophenolate Mofetil in Combination with Temozolomide for Patients with Newly Diagnosed Glioblastoma
霉酚酸酯联合替莫唑胺治疗新诊断胶质母细胞瘤患者的 1 期适应性剂量递增研究
- 批准号:
10626396 - 财政年份:2018
- 资助金额:
$ 43.94万 - 项目类别:
Cellular Plasticity and equilibrium in GBM Progression
GBM 进展中的细胞可塑性和平衡
- 批准号:
10666657 - 财政年份:2017
- 资助金额:
$ 43.94万 - 项目类别:
Cellular Plasticity and equilibrium in GBM Progression
GBM 进展中的细胞可塑性和平衡
- 批准号:
10539645 - 财政年份:2017
- 资助金额:
$ 43.94万 - 项目类别:
Genetically-Modified Neural Stem Cell Based Virotherapy for Invasive Gliomas
基于基因修饰的神经干细胞的病毒疗法治疗侵袭性胶质瘤
- 批准号:
9262538 - 财政年份:2013
- 资助金额:
$ 43.94万 - 项目类别:
Genetically-Modified Neural Stem Cell Based Virotherapy for Invasive Gliomas
基于基因修饰的神经干细胞的病毒疗法治疗侵袭性胶质瘤
- 批准号:
8714430 - 财政年份:2013
- 资助金额:
$ 43.94万 - 项目类别:
相似国自然基金
下一代无线通信系统自适应调制技术及跨层设计研究
- 批准号:60802033
- 批准年份:2008
- 资助金额:16.0 万元
- 项目类别:青年科学基金项目
由蝙蝠耳轮和鼻叶推导新型仿生自适应波束模型的研究
- 批准号:10774092
- 批准年份:2007
- 资助金额:39.0 万元
- 项目类别:面上项目
相似海外基金
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 43.94万 - 项目类别:
Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR)
改善低危髓母细胞瘤幼儿神经认知结果的前瞻性国际 III 期研究 (YCMB-LR)
- 批准号:
10720110 - 财政年份:2023
- 资助金额:
$ 43.94万 - 项目类别:
Early-Stage Clinical Trial of AI-Driven CBCT-Guided Adaptive Radiotherapy for Lung Cancer
AI驱动的CBCT引导的肺癌适应性放疗的早期临床试验
- 批准号:
10575081 - 财政年份:2023
- 资助金额:
$ 43.94万 - 项目类别:
Preclinical validation of small molecule immunomodulators for the treatment of Crohn's disease
小分子免疫调节剂治疗克罗恩病的临床前验证
- 批准号:
10600659 - 财政年份:2023
- 资助金额:
$ 43.94万 - 项目类别:
Project 1: Combining PARP inhibition with radiation to sensitize HR proficient pancreatic cancers to immunotherapy
项目 1:将 PARP 抑制与放射治疗相结合,使 HR 熟练的胰腺癌对免疫治疗敏感
- 批准号:
10554472 - 财政年份:2023
- 资助金额:
$ 43.94万 - 项目类别:
Immunoepigenetic targeting of MHC regulators in FAP
FAP 中 MHC 调节因子的免疫表观遗传学靶向
- 批准号:
10677375 - 财政年份:2023
- 资助金额:
$ 43.94万 - 项目类别:
Fractionated photoimmunotherapy to harness low-dose immunostimulation in ovarian cancer
分段光免疫疗法利用低剂量免疫刺激治疗卵巢癌
- 批准号:
10662778 - 财政年份:2023
- 资助金额:
$ 43.94万 - 项目类别:
A Phase 2, randomized, double-blind, 4-arm, multicenter study to demonstrate the efficacy and safety of topical dosage formulations of a prescription drug product for actinic keratosis
一项 2 期、随机、双盲、4 组、多中心研究,旨在证明处方药局部剂量制剂治疗光化性角化病的有效性和安全性
- 批准号:
10820810 - 财政年份:2023
- 资助金额:
$ 43.94万 - 项目类别:
A Novel Immunological-Directed Biotherapy for Treating Rheumatoid Arthritis
治疗类风湿关节炎的新型免疫导向生物疗法
- 批准号:
10760183 - 财政年份:2023
- 资助金额:
$ 43.94万 - 项目类别:
Immunogenicity of the dengue vaccine CYD-TDV in a dengue virus serotype 1 immune population
登革热疫苗 CYD-TDV 在登革热病毒血清型 1 免疫群体中的免疫原性
- 批准号:
10728086 - 财政年份:2023
- 资助金额:
$ 43.94万 - 项目类别: